Yarrow Bioscience
New Haven, Connecticut, United States · Biotechnology, Healthcare, Health Care
Yarrow Bioscience, Inc. is a biotechnology company focused on developing novel therapies for autoimmune diseases. Founded by RTW Investments, Yarrow is advancing its lead program, YB-101, which targets thyroid-stimulating hormone receptors for the treatment of Graves' disease and thyroid eye disease. The company aims to address significant unmet needs in these therapeutic areas.
Key facts
- Headquarters
- New Haven, Connecticut, United States
- Employees
- 11
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (YARW)
- Website
- yarrowbio.com
- Company page
Recent activity at Yarrow Bioscience
Yarrow Bioscience funding history
| Date | Round | Amount |
|---|---|---|
| Nov 2023 | Venture | $88.2M |
| Nov 2022 | Seed | $300K |
| Jul 2017 | Venture | $50.5M |
Leadership
- Aaron Royston, Director
- Scott Whitcup, Director
- Ted Ebel, Director
- Ketan Patel, Director
- Albert Cha, Director
- John Creecy, Director
- David Collier, Director
- Steven Basta, Executive Officer, Director
- Igor, Chief Scientific Officer
- PATRICK LEPORE, Director
- SHARON BARBARI, Director
- ELISABETH SANDOVAL, Director
Verified email and direct lines for Yarrow Bioscience’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Yarrow Bioscience in the news
Companies similar to Yarrow Bioscience
- Cocrystal Pharma, Inc. · Biotechnology, Healthcare, Health Care, Therapeutics
- Retension Pharmaceuticals · Biotechnology, Healthcare, Health Care, Therapeutics
- Aarvik Therapeutics · Biotechnology, Healthcare, Health Care, Therapeutics
- Galectin · Biotechnology, Healthcare, Health Care, Therapeutics
- Os Therapies · Biotechnology, Healthcare, Health Care, Therapeutics
About Yarrow Bioscience: questions and answers
What does Yarrow Bioscience do?
Yarrow Bioscience, Inc. is a biotechnology company focused on developing novel therapies for autoimmune diseases. Founded by RTW Investments, Yarrow is advancing its lead program, YB-101, which targets thyroid-stimulating hormone receptors for the treatment of Graves' disease and thyroid eye disease. The company aims to address significant unmet needs in these therapeutic areas.
Where is Yarrow Bioscience headquartered?
Yarrow Bioscience is headquartered in New Haven, Connecticut, United States.
How many employees does Yarrow Bioscience have?
Yarrow Bioscience has about 11 employees.
Has Yarrow Bioscience raised funding?
Yes. Fundz has recorded 3 funding events for Yarrow Bioscience. The most recent, $88.2M, was in Nov 2023.
What is the latest news on Yarrow Bioscience?
On Sep 10, 2026, Yarrow Bioscience, Inc. Completes Merger with Yarrow Bioscience Operating Company Corp.
Is Yarrow Bioscience a public company?
Yes. Yarrow Bioscience is publicly traded under the ticker YARW.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy